EW
Edwards Lifesciences Corp
86.30$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.4% | +18.8% | +15.9% | +8.4% | +16.8% | +0.9% | +19.3% | +2.9% | +11.6% | -9.4% | +11.5% | |
| – | +8.4% | +17.8% | +9.6% | +4.4% | +25.3% | -4.9% | +11.5% | -4.8% | +18.2% | -19.0% | +18.7% | |
| – | +7.0% | +19.3% | +18.3% | +9.7% | +14.0% | +3.0% | +21.9% | +5.2% | +9.7% | -6.6% | +9.7% | |
| – | +10.6% | +15.4% | +25.0% | +12.6% | +21.0% | +1.1% | +18.7% | +4.7% | +13.4% | -1.8% | +2.5% | |
| – | -0.9% | +6.3% | +8.8% | +10.5% | +14.1% | -1.1% | +21.6% | +4.9% | +12.1% | +1.9% | +16.5% | |
| – | +2.4% | +8.8% | +14.9% | +10.8% | +16.8% | -0.2% | +20.3% | +4.9% | +15.3% | +1.6% | +5.5% | |
| – | +18.2% | +41.6% | +23.9% | +8.1% | +9.7% | +8.2% | +24.3% | +5.7% | -9.9% | -10.1% | +18.7% | |
| – | -14.8% | -2.2% | +28.9% | +44.0% | -18.3% | -18.7% | +11.7% | +5.6% | -32.8% | +12.5% | +3.0% | |
| – | -45.6% | +18.6% | +40.2% | -26.4% | +53.2% | -21.4% | +85.7% | +3.8% | -9.6% | -3.1% | -17.8% | |
| – | -61.7% | +32.1% | +168.0% | -91.3% | +205.1% | -22.0% | +113.2% | +23.4% | -19.1% | -23.5% | +42.6% | |
| – | -39.0% | +15.1% | +9.2% | +16.1% | +45.0% | -21.3% | +82.5% | +1.3% | -7.9% | +197.7% | -74.3% | |
| – | -42.7% | +17.1% | +37.8% | -23.5% | +50.0% | -17.9% | +75.9% | +3.7% | -21.7% | +12.3% | -17.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.